399 related articles for article (PubMed ID: 33646999)
21. Mirtazapine for severe gastroparesis unresponsive to conventional prokinetic treatment.
Kim SW; Shin IS; Kim JM; Kang HC; Mun JU; Yang SJ; Yoon JS
Psychosomatics; 2006; 47(5):440-2. PubMed ID: 16959934
[TBL] [Abstract][Full Text] [Related]
22. [Extrapyramidal adverse reactions to metoclopramide. A pharmacovigilance survey].
Frez C; Awad Y; Sánchez N; Silva A; Mercado B; Marcotti C; Arévalo P; Apablaza K; Fernández P; Pérez D
Rev Med Chil; 2018 Jul; 146(7):876-884. PubMed ID: 30534887
[TBL] [Abstract][Full Text] [Related]
23. From Harmful Treatment to Secondary Gain: Adverse Event Reporting in Dyspepsia and Gastroparesis.
Bielefeldt K
Dig Dis Sci; 2017 Nov; 62(11):2999-3013. PubMed ID: 28577245
[TBL] [Abstract][Full Text] [Related]
24. Prokinetics in patients with gastroparesis: a systematic analysis.
Sturm A; Holtmann G; Goebell H; Gerken G
Digestion; 1999; 60(5):422-7. PubMed ID: 10473966
[TBL] [Abstract][Full Text] [Related]
25. Diabetic gastroparesis.
Kong MF; Horowitz M
Diabet Med; 2005 Sep; 22 Suppl 4():13-8. PubMed ID: 16109013
[No Abstract] [Full Text] [Related]
26. Drug-drug interactions in pharmacologic management of gastroparesis.
Youssef AS; Parkman HP; Nagar S
Neurogastroenterol Motil; 2015 Nov; 27(11):1528-41. PubMed ID: 26059917
[TBL] [Abstract][Full Text] [Related]
27. Diabetic gastroparesis. A critical reappraisal of new treatment strategies.
Drenth JP; Engels LG
Drugs; 1992 Oct; 44(4):537-53. PubMed ID: 1281070
[TBL] [Abstract][Full Text] [Related]
28. Current pharmacological treatment of gastroparesis.
Vandenplas Y; Hauser B; Salvatore S
Expert Opin Pharmacother; 2004 Nov; 5(11):2251-4. PubMed ID: 15500371
[TBL] [Abstract][Full Text] [Related]
29. Review article: The diagnosis and management of gastroparesis.
Haans JJ; Masclee AA
Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():37-46. PubMed ID: 18081647
[TBL] [Abstract][Full Text] [Related]
30. The metoclopramide black box warning for tardive dyskinesia: effect on clinical practice, adverse event reporting, and prescription drug lawsuits.
Ehrenpreis ED; Deepak P; Sifuentes H; Devi R; Du H; Leikin JB
Am J Gastroenterol; 2013 Jun; 108(6):866-72. PubMed ID: 23735907
[TBL] [Abstract][Full Text] [Related]
31. Prokinetics in gastroparesis.
Acosta A; Camilleri M
Gastroenterol Clin North Am; 2015 Mar; 44(1):97-111. PubMed ID: 25667026
[TBL] [Abstract][Full Text] [Related]
32. Diabetic gastroparesis.
Tarsy D
N Engl J Med; 2007 Jul; 357(4):419; author reply 419-20. PubMed ID: 17663032
[No Abstract] [Full Text] [Related]
33. A systematic review of the efficacy of domperidone for the treatment of diabetic gastroparesis.
Sugumar A; Singh A; Pasricha PJ
Clin Gastroenterol Hepatol; 2008 Jul; 6(7):726-33. PubMed ID: 18524689
[TBL] [Abstract][Full Text] [Related]
34. Dopamine D₂-receptor antagonists ameliorate indomethacin-induced small intestinal ulceration in mice by activating α7 nicotinic acetylcholine receptors.
Yasuda M; Kawahara R; Hashimura H; Yamanaka N; Iimori M; Amagase K; Kato S; Takeuchi K
J Pharmacol Sci; 2011; 116(3):274-82. PubMed ID: 21691039
[TBL] [Abstract][Full Text] [Related]
35. Comparison of metoclopramide and erythromycin in the treatment of diabetic gastroparesis.
Erbas T; Varoglu E; Erbas B; Tastekin G; Akalin S
Diabetes Care; 1993 Nov; 16(11):1511-4. PubMed ID: 8299441
[TBL] [Abstract][Full Text] [Related]
36. [Gastroparesis and its treatment options].
Igaz P; Tulassay Z
Orv Hetil; 2008 Mar; 149(9):393-8. PubMed ID: 18292033
[TBL] [Abstract][Full Text] [Related]
37. Metoclopramide suppositories in the treatment of diabetic gastroparesis.
Trapnell BC; Mavko LE; Birskovich LM; Falko JM
Arch Intern Med; 1986 Nov; 146(11):2278-9. PubMed ID: 3778059
[TBL] [Abstract][Full Text] [Related]
38. Metoclopramide nasal spray in vitro evaluation and in vivo pharmacokinetic studies in dogs.
Li Y; Fan X; Li W; Yang P; Zhang H; Tang D; Yin X; Sun J; Zheng A
Pharm Dev Technol; 2018 Mar; 23(3):275-281. PubMed ID: 28379057
[TBL] [Abstract][Full Text] [Related]
39. Effect of metoclopramide in diabetic gastroparesis.
Ricci DA; Saltzman MB; Meyer C; Callachan C; McCallum RW
J Clin Gastroenterol; 1985 Feb; 7(1):25-32. PubMed ID: 3884697
[TBL] [Abstract][Full Text] [Related]
40. Drug Insight: from disturbed motility to disordered movement--a review of the clinical benefits and medicolegal risks of metoclopramide.
Pasricha PJ; Pehlivanov N; Sugumar A; Jankovic J
Nat Clin Pract Gastroenterol Hepatol; 2006 Mar; 3(3):138-48. PubMed ID: 16511548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
